Globus MedicalMEX:GMED 92 Piotroski F-Score is 8 as of Jun. 30, 2026, which is 33% above its 10-year median of 6.00. GuruFocus rates MEX:GMED with a GF Score™ of 92/100 and a GF Value™ of MXN1,721.21 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Globus Medical ranks better than 98.76% on this metric.
Good Sign:
Piotroski F-Score is 8, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Globus Medical has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Globus Medical's Piotroski F-Score or its related term are showing as below:
MEX:GMED'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 6 Max: 8
Current: 8
During the past 13 years, the highest Piotroski F-Score of Globus Medical was 8. The lowest was 4. And the median was 6.
Globus Medical (MEX:GMED) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Globus Medical Piotroski F-Score Related Terms
Globus Medical Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Globus Medical's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:GMED vs PEN, PODD, BRKR: Piotroski F-Score Comparison
For the Medical Devices subindustry, Globus Medical's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Globus Medical's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Mar26) TTM:
Last Year (Mar25) TTM:
Net Income was 3819.428 + 2182.336 + 2531.493 + 2241.501 = MXN10,775 Mil. Cash Flow from Operations was 1466.136 + 4580.455 + 4475.983 + 3649.169 = MXN14,172 Mil. Revenue was 14034.194 + 14107.57 + 14880.271 + 13702.219 = MXN56,724 Mil. Gross Profit was 9350.148 + 9475.054 + 10178.856 + 9481.377 = MXN38,485 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(96381.608 + 93413.337 + 93475.439 + 95479.924 + 98089.864) / 5 = MXN95368.0344 Mil. Total Assets at the begining of this year (Mar25) was MXN96,382 Mil. Long-Term Debt & Capital Lease Obligation was MXN1,805 Mil. Total Current Assets was MXN39,638 Mil. Total Current Liabilities was MXN8,700 Mil.
Net Income was 581.846 + 1020.666 + 552.78 + 1543.817 = MXN3,699 Mil.
Revenue was 11536.004 + 12320.319 + 13708.306 + 12236.479 = MXN49,801 Mil. Gross Profit was 6772.044 + 6993.798 + 8214.143 + 8239.008 = MXN30,219 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(82045.445 + 91486.802 + 100145.732 + 109528.922 + 96381.608) / 5 = MXN95917.7018 Mil. Total Assets at the begining of last year (Mar24) was MXN82,045 Mil. Long-Term Debt & Capital Lease Obligation was MXN1,671 Mil. Total Current Assets was MXN34,986 Mil. Total Current Liabilities was MXN7,870 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Globus Medical's current Net Income (TTM) was 10,775.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Globus Medical's return on assets of this year was 0.11179268. Globus Medical's return on assets of last year was 0.0450861.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Globus Medical's gearing of this year was 0.01892782. Globus Medical's gearing of last year was 0.0174238.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Globus Medical's current ratio of this year was 4.55603831. Globus Medical's current ratio of last year was 4.44530684.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Globus Medical's number of shares in issue this year was 138.191. Globus Medical's number of shares in issue last year was 139.774.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Globus Medical's gross margin of this year was 0.67846525. Globus Medical's gross margin of last year was 0.60679359.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Globus Medical's asset turnover of this year was 0.58853816. Globus Medical's asset turnover of last year was 0.60699418.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
0
+
1
+
1
+
1
+
0
=
7
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Globus Medical has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
Globus Medical (MEX:GMED) has a Piotroski F-Score of 8 as of Jun. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Globus Medical and its competitors. This is 33% above median its historical median of 6.00. Over the past decade, Globus Medical's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, Globus Medical ranks #10 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 1.2%.
Is Globus Medical's Piotroski F-Score too high?
Globus Medical's current Piotroski F-Score of 8 is 33% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Globus Medical's value of 8 is 60% above this industry median. Based on the distribution chart, Globus Medical ranks #10 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Piotroski F-Score compare to PEN and PODD?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #10 out of 806 companies for Piotroski F-Score. This places Globus Medical in the top 1% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Globus Medical's value of 8 is 60% above this benchmark. Historically, Globus Medical's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Globus Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globus Medical's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Globus Medical and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globus Medical's current Piotroski F-Score is 8, which is 33% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,721.21, compared to a current price of MXN1,465.00 — trading 14.9% below its estimated fair value. The current Piotroski F-Score is 8, which is 33% above median its 10-year median of 6.00 and 60% above the Medical Devices & Instruments industry median of 5.00. Globus Medical's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current Piotroski F-Score is 8 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (MEX:GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of MXN1,465.00 is trading 14.9% below its estimated GF Value™ of MXN1,721.21.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for MEX:GMED:
Piotroski F-Score: 8 (33% above median its 10-year median of 6.00)
GF Value™: MXN1,721.21 vs. price of MXN1,465.00 (14.9% below fair value)
Industry Position: 60% above the Medical Devices & Instruments median (#10 of 806)
No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
92GF Score
Get the complete analysis for MEX:GMED
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GMED has been successfully added to your 
